Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Rice Hall James & Associates LLC
Rice Hall James & Associates LLC lowered its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 5.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,846 shares of the business services provider’s stock after selling 2,426 shares during the period. Rice Hall James & Associates LLC’s holdings in Exponent were worth $2,323,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank bought a new position in shares of Exponent during the fourth quarter worth approximately $14,612,000. Bank of Montreal Can raised its position in shares of Exponent by 21.8% in the first quarter. Bank of Montreal Can now owns 3,209 shares of the business services provider’s stock worth $192,000 after buying an additional 575 shares in the last quarter. Louisiana State Employees Retirement System raised its position in shares of Exponent by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,400 shares of the business services provider’s stock worth $619,000 after buying an additional 100 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in shares of Exponent by 7.5% in the first quarter. Conestoga Capital Advisors LLC now owns 628,897 shares of the business services provider’s stock worth $37,451,000 after buying an additional 43,615 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in shares of Exponent by 0.7% in the first quarter. State of Alaska Department of Revenue now owns 2,830 shares of the business services provider’s stock worth $168,000 after buying an additional 20 shares in the last quarter. 90.37% of the stock is owned by institutional investors and hedge funds.
Exponent, Inc. (EXPO) opened at 65.00 on Monday. The firm has a market cap of $1.68 billion, a price-to-earnings ratio of 33.70 and a beta of 0.62. Exponent, Inc. has a 12 month low of $48.42 and a 12 month high of $68.30. The stock’s 50 day moving average is $61.97 and its 200-day moving average is $59.88.
Exponent (NASDAQ:EXPO) last posted its earnings results on Tuesday, July 18th. The business services provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.10. The company had revenue of $84.10 million during the quarter, compared to analysts’ expectations of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. Exponent’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.38 EPS. On average, analysts anticipate that Exponent, Inc. will post $1.97 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Stockholders of record on Friday, September 1st will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date is Wednesday, August 30th. Exponent’s dividend payout ratio is presently 43.52%.
COPYRIGHT VIOLATION WARNING: “Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Rice Hall James & Associates LLC” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/14/exponent-inc-nasdaqexpo-shares-sold-by-rice-hall-james-associates-llc.html.
EXPO has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Exponent from a “buy” rating to a “hold” rating in a research report on Wednesday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $69.00 price objective (up previously from $64.00) on shares of Exponent in a research report on Saturday, April 22nd. BidaskClub lowered shares of Exponent from a “hold” rating to a “sell” rating in a research report on Tuesday, June 20th. Finally, ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th.
In other news, CEO Paul R. Johnston sold 5,858 shares of the firm’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $65.60, for a total transaction of $384,284.80. Following the completion of the sale, the chief executive officer now owns 67,193 shares in the company, valued at approximately $4,407,860.80. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Sally Shepard sold 1,255 shares of the firm’s stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $65.37, for a total transaction of $82,039.35. Following the sale, the insider now owns 1,560 shares of the company’s stock, valued at approximately $101,977.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 31,855 shares of company stock valued at $2,099,002. 2.80% of the stock is currently owned by corporate insiders.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.